88 related articles for article (PubMed ID: 29271993)
21. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway.
Wang L; Zhao Z; Feng W; Ye Z; Dai W; Zhang C; Peng J; Wu K
Oncotarget; 2016 Aug; 7(32):51713-51719. PubMed ID: 27421138
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
24. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
25. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
Lei H; Gao Y; Xu X
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
27. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiological Functions of the lncRNA TUG1.
Guo C; Qi Y; Qu J; Gai L; Shi Y; Yuan C
Curr Pharm Des; 2020; 26(6):688-700. PubMed ID: 31880241
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
30. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
31. [Expression of AIB1 protein in gynecological tumors].
Han XY; Zhang XM; Chen Y; Yang KX; Qie MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):246-9. PubMed ID: 17441340
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
Cai H; Liu X; Zheng J; Xue Y; Ma J; Li Z; Xi Z; Li Z; Bao M; Liu Y
Oncogene; 2017 Jan; 36(3):318-331. PubMed ID: 27345398
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
34. TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a.
Yang B; Tang X; Wang Z; Sun D; Wei X; Ding Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29967294
[TBL] [Abstract][Full Text] [Related]
35. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
[TBL] [Abstract][Full Text] [Related]
37. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
[TBL] [Abstract][Full Text] [Related]
38. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of the long non-coding RNA taurine-upregulated gene 1 inhibits glioma cell proliferation and invasion and promotes apoptosis.
Zhao Z; Wang B; Hao J; Man W; Chang Y; Ma S; Hu Y; Liu F; Yang J
Oncol Lett; 2018 Mar; 15(3):4026-4032. PubMed ID: 29467911
[TBL] [Abstract][Full Text] [Related]
40. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.
Shi J; Liu W; Sui F; Lu R; He Q; Yang Q; Lv H; Shi B; Hou P
Oncotarget; 2015 Jun; 6(16):14344-59. PubMed ID: 25970779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
